Cancer therapy and synthetic biology are converging around a shared problem that has long frustrated oncologists and ...

Randomness inside cells can decide whether a cancer returns after chemotherapy or whether an infection survives antibiotics.

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity on both tumor growth and cancer cell spread. MIAMI, FLORIDA / ACCESS ...

Incyte said on Monday its experimental combo therapy helped patients with a type of blood cancer live longer without their ...

Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable ...

If you smoke and want to quit, call the national quit line at 1-800-784-8669 to speak with a confidential coach. In what ...

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...

“We are encouraged by the emerging data from our lung cancer programs, where systemically delivered Olvi-Vec continues to ...

Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...

Northwestern scientists said they found pancreatic cancer cells play a trick on a person's immune system by wearing a sugar ...

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...